These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27764811)

  • 21. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.
    Arora A; Abdel-Fatah TM; Agarwal D; Doherty R; Croteau DL; Moseley PM; Hameed K; Green A; Aleskandarany MA; Rakha EA; Patterson K; Ball G; Chan SY; Ellis IO; Bohr VA; Bryant HE; Madhusudan S
    Carcinogenesis; 2016 Jan; 37(1):63-71. PubMed ID: 26586793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human RECQL5 participates in the removal of endogenous DNA damage.
    Tadokoro T; Ramamoorthy M; Popuri V; May A; Tian J; Sykora P; Rybanska I; Wilson DM; Croteau DL; Bohr VA
    Mol Biol Cell; 2012 Nov; 23(21):4273-85. PubMed ID: 22973052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in 3'-long terminal repeat of HERV-W family in chromosome 7 upregulate syncytin-1 expression in urothelial cell carcinoma of the bladder through interacting with c-Myb.
    Yu H; Liu T; Zhao Z; Chen Y; Zeng J; Liu S; Zhu F
    Oncogene; 2014 Jul; 33(30):3947-58. PubMed ID: 24013223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
    Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
    Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
    Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of miR-143 reduces growth and migration of human bladder carcinoma cells by targeting cyclooxygenase-2.
    Song T; Zhang X; Wang C; Wu Y; Dong J; Gao J; Cai W; Hong B
    Asian Pac J Cancer Prev; 2011; 12(4):929-33. PubMed ID: 21790228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma.
    Shang C; Guo Y; Zhang H; Xue YX
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):507-13. PubMed ID: 26781446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
    Zhang Z; Zhang G; Kong C
    Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular biology and targeted therapies for urothelial carcinoma.
    Seront E; Machiels JP
    Cancer Treat Rev; 2015 Apr; 41(4):341-53. PubMed ID: 25828962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.
    Khadka P; Hsu JK; Veith S; Tadokoro T; Shamanna RA; Mangerich A; Croteau DL; Bohr VA
    Mol Cell Biol; 2015 Dec; 35(23):3974-89. PubMed ID: 26391948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic Instability.
    Chen E; Ahn JS; Sykes DB; Breyfogle LJ; Godfrey AL; Nangalia J; Ko A; DeAngelo DJ; Green AR; Mullally A
    Cell Rep; 2015 Dec; 13(11):2345-2352. PubMed ID: 26686625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of nm23-H1 in the progression of transitional cell bladder cancer.
    Chow NH; Liu HS; Chan SH
    Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
    Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF
    J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.
    Shamanna RA; Lu H; Croteau DL; Arora A; Agarwal D; Ball G; Aleskandarany MA; Ellis IO; Pommier Y; Madhusudan S; Bohr VA
    Oncotarget; 2016 Mar; 7(12):13269-84. PubMed ID: 26959889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the Bladder following Radical Cystectomy.
    Klatte T; Seitz C; Rink M; Rouprêt M; Xylinas E; Karakiewicz P; Susani M; Shariat SF
    J Urol; 2015 Nov; 194(5):1456-62. PubMed ID: 26162296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RECQ DNA helicases and osteosarcoma.
    Lu L; Jin W; Liu H; Wang LL
    Adv Exp Med Biol; 2014; 804():129-45. PubMed ID: 24924172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human RECQL5beta stimulates flap endonuclease 1.
    Speina E; Dawut L; Hedayati M; Wang Z; May A; Schwendener S; Janscak P; Croteau DL; Bohr VA
    Nucleic Acids Res; 2010 May; 38(9):2904-16. PubMed ID: 20081208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma.
    Liu H; Schwartz MJ; Hwang DH; Scherr DS
    BJU Int; 2008 Apr; 101(7):894-901. PubMed ID: 18241249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma.
    Liu D; Plimack ER; Hoffman-Censits J; Garraway LA; Bellmunt J; Van Allen E; Rosenberg JE
    JAMA Oncol; 2016 Aug; 2(8):1094-6. PubMed ID: 27310333
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.